Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H (SFOSF)
OTHER OTC:SFOSF
RESEARCH TOOLSreports
Shanghai Fosun Pharmaceutical (Group) Co (SFOSF) Stock Price & Analysis
20 Followers
SFOSF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.35 - $2.78
Previous Close$1.74
Volume200.00
Average Volume (3M)2.16K
Market Cap
$7.55B
Enterprise Value$10.67B
Total Cash (Recent Filing)¥17.17B
Total Debt (Recent Filing)¥30.25B
Price to Earnings (P/E)16.5
Beta0.11
Next Earnings
Aug 28, 2024EPS Estimate
$0.04Last Dividend Ex-Date
Jul 26, 2024Dividend Yield3.38%
Share Statistics
EPS (TTM)0.10
Shares Outstanding551,940,500
10 Day Avg. Volume9,050
30 Day Avg. Volume2,156
Standard Deviation0.15
R-Squared0.04
Alpha-0.00626
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Shanghai Fosun Pharmaceutical (Group) Co News
PremiumCompany Announcements
Fosun Pharma Announces New Drug Acceptance
PremiumCompany Announcements
Fosun Pharma’s New Drug Application Accepted
PremiumCompany Announcements
Fosun Pharma Announces Corporate Governance Update
PremiumCompany Announcements
Fosun Pharma Announces Merger Delay
PremiumCompany Announcements
Fosun Pharma Advances Towards Henlius Privatization
PremiumCompany Announcements
Fosun Pharma Subsidiary Gains Drug Approval
PremiumCompany Announcements
Fosun Pharma Advances Cancer Treatment Trial
PremiumCompany Announcements
Shanghai Fosun Pharma Announces Board StructureOptions Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
6.18% Mutual Funds
2.09% Other Institutional Investors
91.73% Public Companies and
Individual Investors
SFOSF FAQ
What was Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s price range in the past 12 months?
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H lowest stock price was $1.35 and its highest was $2.78 in the past 12 months.
What is Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s market cap?
Currently, no data Available
When is Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s upcoming earnings report date?
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s upcoming earnings report date is Aug 28, 2024 which is in 33 days.
How were Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s earnings last quarter?
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H released its earnings results on Apr 29, 2024. The company reported $0.032 earnings per share for the quarter, missing the consensus estimate of $0.037 by -$0.006.
Is Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H overvalued?
According to Wall Street analysts Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s price is currently Overvalued.
Does Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H pay dividends?
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H pays a Annually dividend of $0.04 which represents an annual dividend yield of 3.38%. See more information on Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H dividends here
What is Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s EPS estimate?
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s EPS estimate is $0.04.
How many shares outstanding does Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H have?
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H has 551,940,500 shares outstanding.
What happened to Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s price movement after its last earnings report?
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H reported an EPS of $0.032 in its last earnings report, missing expectations of $0.037. Following the earnings report the stock price went down -0.641%.
Which hedge fund is a major shareholder of Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H?
Currently, no hedge funds are holding shares in SFOSF
---
Shanghai Fosun Pharmaceutical (Group) Co Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-34.83%
12-Months-Change
Fundamentals
Return on Equity
4.32%
Trailing 12-Months
Asset Growth
0.72%
Trailing 12-Months
Company Description
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H
Shanghai Fosun Pharmaceutical Group Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products and medical equipment, import and export of medical equipment, healthcare services, and the provision of related and other consulting services and investment management. It operates through the following business segment: Pharmaceutical Manufacturing and R&D; Healthcare Service; Medical Devices and Medical Diagnosis; Pharmaceutical Distribution and Retail; and Other Business Operations. The Pharmaceutical Manufacturing and R&D segment involves in the production, sale, and research of medicine. The Healthcare Service segment provides healthcare service and hospital management. The Medical Devices and Medical Diagnosis segment focuses on the production and sale of medical equipment and diagnostic products. The Pharmaceutical Distribution and Retail segment issue retail and wholesale of medicine. The Other Business Operations segment comprises business that is different from the role of other segments. The company was founded on January 14, 1994 and is headquartered in Shanghai, China.
---
SFOSF Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---